Literature DB >> 1370620

Expression of cell-adhesion molecules in the salivary gland microenvironment of Sjögren's syndrome.

E W St Clair1, J C Angellilo, K H Singer.   

Abstract

OBJECTIVE: The potential role of cell adhesion molecules in the pathogenesis of Sjögren's syndrome (SS) was assessed by examining their expression in salivary gland (SGL) tissue.
METHODS: Intercellular adhesion molecule type 1 (ICAM-1), lymphocyte function-associated antigen type 1 (LFA-1), LFA-3, CD2, and CD44 expression were determined using indirect immunofluorescence techniques.
RESULTS: In inflamed labial SGL tissue, ICAM-1 expression was evident on infiltrating LFA-1+/CD2+/LFA-3+ mononuclear cells, and to a limited extent on SGL acinar epithelial cells adjacent to sites of intense inflammation.
CONCLUSION: In SS, the SGL microenvironment is characterized by only a modest up-regulation of ICAM-1 expression on epithelial cells, despite the presence of T cells bearing an activated phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370620     DOI: 10.1002/art.1780350110

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells.

Authors:  E K Kapsogeorgou; I D Dimitriou; R F Abu-Helu; H M Moutsopoulos; M N Manoussakis
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line.

Authors:  Olga J Baker; Jean M Camden; Danny E Rome; Cheikh I Seye; Gary A Weisman
Journal:  Mol Immunol       Date:  2007-06-27       Impact factor: 4.407

3.  Molecular Targeting of Immunosuppressants Using a Bifunctional Elastin-Like Polypeptide.

Authors:  Yaping Ju; Hao Guo; Frances Yarber; Maria C Edman; Santosh Peddi; Srikanth Reddy Janga; J Andrew MacKay; Sarah F Hamm-Alvarez
Journal:  Bioconjug Chem       Date:  2019-08-23       Impact factor: 4.774

4.  Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.

Authors:  Sreedevi Chinthamani; Olutayo Odusanwo; Nandini Mondal; Joel Nelson; Sriram Neelamegham; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-28       Impact factor: 4.249

5.  ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis.

Authors:  R M Flipo; T Cardon; M C Copin; M Vandecandelaere; B Duquesnoy; A Janin
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

6.  Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.

Authors:  J Krejsek; R Slezák; O Kopecky; V Derner; C Andrys
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

7.  Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice.

Authors:  N L McCartney-Francis; D E Mizel; M Frazier-Jessen; A B Kulkarni; J B McCarthy; S M Wahl
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 8.  The role of epithelial cells in the pathogenesis of Sjögren's syndrome.

Authors:  Menelaos N Manoussakis; Efstathia K Kapsogeorgou
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

9.  Neovascularization is prominent in the chronic inflammatory lesions of Sjögren's syndrome.

Authors:  Margherita Sisto; Sabrina Lisi; Giuseppe Ingravallo; Dario Domenico Lofrumento; Massimo D'Amore; Domenico Ribatti
Journal:  Int J Exp Pathol       Date:  2014-04       Impact factor: 1.925

10.  Prevention of adoptive transfer of murine Sjögren's syndrome into severe combined immunodeficient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1).

Authors:  Y Hayashi; N Haneji; K Yanagi; H Higashiyama; H Yagita; H Hamano
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.